Recently, molecular mechanisms governing the oncogenic potential of SOX2 in breast cancer were elucidated, indicating that this transcription factor promotes cell proliferation and tumourigenesis by facilitating the G1/S transition and through its transcriptional regulation of the CCNDS gene in breast cancer cells. This evidence concerns the gene SOX2 and breast carcinoma.